IRIS Accounts Production v24.2.0.383 05766627 Board of Directors 1.2.23 31.1.24 31.1.24 true false true true false false true false A Shares 0.0500 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh057666272023-01-31057666272024-01-31057666272023-02-012024-01-31057666272022-01-31057666272022-02-012023-01-31057666272023-01-3105766627ns15:EnglandWales2023-02-012024-01-3105766627ns14:PoundSterling2023-02-012024-01-3105766627ns10:Director12023-02-012024-01-3105766627ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3105766627ns10:FRS1022023-02-012024-01-3105766627ns10:Audited2023-02-012024-01-3105766627ns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2023-02-012024-01-3105766627ns10:LargeMedium-sizedCompaniesRegimeForAccounts2023-02-012024-01-3105766627ns10:FullAccounts2023-02-012024-01-3105766627ns10:OrdinaryShareClass12023-02-012024-01-3105766627ns10:Director22023-02-012024-01-3105766627ns10:CompanySecretary12023-02-012024-01-3105766627ns10:RegisteredOffice2023-02-012024-01-3105766627ns5:CurrentFinancialInstruments2024-01-3105766627ns5:CurrentFinancialInstruments2023-01-3105766627ns5:Non-currentFinancialInstruments2024-01-3105766627ns5:Non-currentFinancialInstruments2023-01-3105766627ns5:ShareCapital2024-01-3105766627ns5:ShareCapital2023-01-3105766627ns5:CapitalRedemptionReserve2024-01-3105766627ns5:CapitalRedemptionReserve2023-01-3105766627ns5:RetainedEarningsAccumulatedLosses2024-01-3105766627ns5:RetainedEarningsAccumulatedLosses2023-01-3105766627ns5:ShareCapital2022-01-3105766627ns5:RetainedEarningsAccumulatedLosses2022-01-3105766627ns5:CapitalRedemptionReserve2022-01-3105766627ns5:RetainedEarningsAccumulatedLosses2022-02-012023-01-3105766627ns5:CapitalRedemptionReserve2022-02-012023-01-3105766627ns5:RetainedEarningsAccumulatedLosses2023-02-012024-01-3105766627ns5:CapitalRedemptionReserve2023-02-012024-01-3105766627ns5:OwnedOrFreeholdAssetsns5:LandBuildings2023-02-012024-01-3105766627ns5:FurnitureFittings2023-02-012024-01-3105766627ns5:ReportableOperatingSegment12023-02-012024-01-3105766627ns5:ReportableOperatingSegment12022-02-012023-01-3105766627ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2023-02-012024-01-3105766627ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2022-02-012023-01-3105766627ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-02-012024-01-3105766627ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2022-02-012023-01-3105766627ns5:OwnedAssets2023-02-012024-01-3105766627ns5:OwnedAssets2022-02-012023-01-310576662712023-02-012024-01-310576662712022-02-012023-01-3105766627ns5:LandBuildings2023-01-3105766627ns5:FurnitureFittings2023-01-3105766627ns5:LandBuildings2023-02-012024-01-3105766627ns5:LandBuildings2024-01-3105766627ns5:FurnitureFittings2024-01-3105766627ns5:LandBuildings2023-01-3105766627ns5:FurnitureFittings2023-01-3105766627ns5:AcceleratedTaxDepreciationDeferredTax2024-01-3105766627ns5:AcceleratedTaxDepreciationDeferredTax2023-01-3105766627ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3105766627ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-3105766627ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-01-3105766627ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-01-3105766627ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-01-3105766627ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-01-3105766627ns5:WithinOneYear2024-01-3105766627ns5:WithinOneYear2023-01-3105766627ns5:BetweenOneFiveYears2024-01-3105766627ns5:BetweenOneFiveYears2023-01-3105766627ns5:AllPeriods2024-01-3105766627ns5:AllPeriods2023-01-3105766627ns5:Secured2024-01-3105766627ns5:Secured2023-01-3105766627ns10:OrdinaryShareClass12024-01-3105766627ns5:RetainedEarningsAccumulatedLosses2023-01-3105766627ns5:CapitalRedemptionReserve2023-01-3105766627ns5:OtherRelatedParties2023-02-012024-01-3105766627ns5:OtherRelatedParties2024-01-3105766627ns5:OtherRelatedParties2023-01-31
REGISTERED NUMBER: 05766627 (England and Wales)















UNITED HEALTH GROUP LIMITED

STRATEGIC REPORT,

REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2024






UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024




Page

Company Information 1

Strategic Report 2 to 3

Report of the Directors 4

Report of the Independent Auditors 5 to 7

Income Statement 8

Other Comprehensive Income 9

Statement of Financial Position 10

Statement of Changes in Equity 11

Statement of Cash Flows 12

Notes to the Statement of Cash Flows 13

Notes to the Financial Statements 14 to 20


UNITED HEALTH GROUP LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2024







DIRECTORS: P J Pearson
M T Cheriton-Metcalfe



SECRETARY: J L Flintham



REGISTERED OFFICE: The Old Coach House
Gainsborough Road
Drinsey Nook
Lincoln
Lincolnshire
LN1 2JJ



REGISTERED NUMBER: 05766627 (England and Wales)



SENIOR STATUTORY AUDITOR: Timothy Godson FCA



AUDITORS: Duncan & Toplis Audit Limited, Statutory Auditor
4 Henley Way
Doddington Road
Lincoln
Lincolnshire
LN6 3QR

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 JANUARY 2024

The directors present their strategic report for the year ended 31 January 2024.

REVIEW OF BUSINESS
We aim to present a balanced and comprehensive review of the development of out company during the period and its position at the period end. Our review is consistent with the size and non complex nature of our business and is written in the context of the risks and uncertainties we face.

During the period, the company continues to operate a number of residential nursing care facilities.

We consider that our key performance indicators are those that communicate the financial performance and strength of the company as a whole, these being turnover, profits before tax and net assets. In addition to financial indicators, occupancy is also considered to be a key performance indicator.

Administrative expenditure is in line with the previous period.

The current economic conditions do provide an element of uncertainly over the level of funding available for the type of services provided by the company.

In our opinion, the company will have sufficient resources available to manage its business risks and we expect that the present level of activity will be sustained for the foreseeable future.

PRINCIPAL RISKS AND UNCERTAINTIES
The company is affected by a number of factors, the principal ones of which are:

- The company is exposed to the risk of negative developments in financial markets and the sectors in which it operates, either directly or through the impact on the company's bankers, suppliers or customers. These developments can result in recession, inflation, deflation, restrictions in the availability of credit, impact on demand from customers, problems in the supplier base, increases in financing costs or in the cost of utilities. Such developments might increase operating costs, reduce revenues, lower asset values or result in the businesses being unable to meet in full its strategic objectives.

- The company operates in a competitive market, and failure to compete effectively in terms of price and quality can have an adverse effect on demand and / or margins.

The company mitigates risk in several ways:

- The company has in place an organisational structure with clearly defined lines of responsibility and delegation of authority. There are established policies and procedures for the setting of corporate strategies; financial planning and budgeting; for information and reporting systems; for systems of operational and financial internal control; for assessment of risk; and for monitoring operations and performance.

- Management and staff at all levels work closely with customers and suppliers to operate as effectively and efficiently as possible, whilst maintaining long term working relationships, innovation and good lines of communication.

- The company operates a recruitment and selection process to ensure employees are experienced and competent in their work. The workforce is trained to be alert, responsive to customer needs, and to operate in line with the company's corporate objectives.

POSITION AT THE FINANCIAL REPORTING DATE
The directors consider the company to be in a solid financial position at the financial position date, with accumulated distributable reserves of approximately £2,828,000.

Management remains mindful of the competitive environment in which the company operates and the need to maintain close control over the company's working capital and financial position.


UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 JANUARY 2024

BORROWINGS AND RISK MANAGEMENT
The company's principal financial instruments comprise bank balances, trade creditors and trade debtors. The main purpose of these instruments is to raise funds for the group operations and capital investment. The company's approach to managing other risks applicable to the financial instruments minimised the risk to a level that the Directors consider acceptable.

Trade debtors are managed in respect of credit and cash flow risk by policies concerning the credit offered to customers and the regular monitoring of amounts outstanding for both time and credit limits.

Trade creditors liquidity risk is managed by ensuring sufficient funds are available to meet amounts due.

ON BEHALF OF THE BOARD:





P J Pearson - Director


6 September 2024

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 JANUARY 2024

The directors present their report with the financial statements of the company for the year ended 31 January 2024.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of providing residential nursing care facilities.

DIVIDENDS
No dividends will be distributed for the year ended 31 January 2024.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 February 2023 to the date of this report.

P J Pearson
M T Cheriton-Metcalfe

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

ON BEHALF OF THE BOARD:





P J Pearson - Director


6 September 2024

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
UNITED HEALTH GROUP LIMITED

Opinion
We have audited the financial statements of United Health Group Limited (the 'company') for the year ended 31 January 2024 which comprise the Income Statement, Other Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, Statement of Cash Flows and Notes to the Statement of Cash Flows, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 January 2024 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
UNITED HEALTH GROUP LIMITED


Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page four, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

We have identified areas of laws and regulations that could reasonably be expected to have a material effect on the financial statements from our general commercial experience, knowledge of the sector, a review of regulatory and legal correspondence and through discussions with Directors and other management obtained as part of the work required by auditing standards. We have also discussed with the Directors and other management the policies and procedures relating to compliance with laws and regulations. We communicated laws and regulations throughout the team and remained alert to any indications of non-compliance throughout the audit.

The potential impact of different laws and regulations varies considerably. Firstly, the company is subject to laws and regulations that directly impact the financial statements (for example financial reporting legislation) and we have assessed the extent of compliance with such laws as part of our financial statements audit. We evaluated management incentives and opportunities for fraudulent manipulation of the financial statements, (including risk of override of controls) and determined that the principal risks were related to management bias in accounting estimate and judgemental areas of the financial statements such as depreciation of tangible fixed asset, as well as the risk of inappropriate journal entries to increase reported profitability. Audit procedures performed by the engagement team included the identification and testing of material and unusual journal entries and challenging management on key accounting estimates, assumptions and judgements made in preparation of the financial statements.

Secondly, the company is subject to other laws and regulations where the consequence for non-compliance could have a material effect on the amounts or disclosures in the financial statements. We identified compliance with Care Quality Commission (CQC) regulations as most likely to have such an effect.

Auditing standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of the Directors and other management and inspection. We inspected the latest CQC inspection reports from visits in the year for any instances of non-compliance and discussed with management the impact of the outcomes of these visits on operations of the care homes. Through these procedures, if we became aware of any non-compliance, we considered the impact on the procedures performed on the related financial statement items.

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. The further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by auditing standards would identify it. As with any audit, there is a greater risk of non-detection of irregularities as these may involve collusion, intentional omissions of the override of internal controls.

We are not responsible for preventing non-compliance and cannot be expected to detect non-compliance with all laws and regulations.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
UNITED HEALTH GROUP LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Timothy Godson FCA (Senior Statutory Auditor)
for and on behalf of Duncan & Toplis Audit Limited, Statutory Auditor
4 Henley Way
Doddington Road
Lincoln
Lincolnshire
LN6 3QR

9 September 2024

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

INCOME STATEMENT
FOR THE YEAR ENDED 31 JANUARY 2024

2024 2023
Notes £    £   

TURNOVER 3 5,382,120 4,814,462

Cost of sales 3,507,999 3,186,577
GROSS PROFIT 1,874,121 1,627,885

Administrative expenses 943,430 990,422
930,691 637,463

Other operating income 3,371 40,076
OPERATING PROFIT 5 934,062 677,539


Interest payable and similar expenses 6 406,355 242,856
PROFIT BEFORE TAXATION 527,707 434,683

Tax on profit 7 185,474 133,784
PROFIT FOR THE FINANCIAL YEAR 342,233 300,899

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 JANUARY 2024

2024 2023
Notes £    £   

PROFIT FOR THE YEAR 342,233 300,899


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE YEAR 342,233 300,899

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

STATEMENT OF FINANCIAL POSITION
31 JANUARY 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 8 13,729,910 13,992,745

CURRENT ASSETS
Debtors 9 839,768 830,822
Cash at bank and in hand 541,972 440,862
1,381,740 1,271,684
CREDITORS
Amounts falling due within one year 10 7,171,470 12,777,532
NET CURRENT LIABILITIES (5,789,730 ) (11,505,848 )
TOTAL ASSETS LESS CURRENT LIABILITIES 7,940,180 2,486,897

CREDITORS
Amounts falling due after more than one year 11 5,111,050 -
NET ASSETS 2,829,130 2,486,897

CAPITAL AND RESERVES
Called up share capital 15 474 474
Capital redemption reserve 16 474 474
Retained earnings 16 2,828,182 2,485,949
SHAREHOLDERS' FUNDS 2,829,130 2,486,897

The financial statements were approved by the Board of Directors and authorised for issue on 6 September 2024 and were signed on its behalf by:





P J Pearson - Director


UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JANUARY 2024

Called up Capital
share Retained redemption Total
capital earnings reserve equity
£    £    £    £   
Balance at 1 February 2022 474 2,185,050 474 2,185,998

Changes in equity
Total comprehensive income - 300,899 - 300,899
Balance at 31 January 2023 474 2,485,949 474 2,486,897

Changes in equity
Total comprehensive income - 342,233 - 342,233
Balance at 31 January 2024 474 2,828,182 474 2,829,130

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 JANUARY 2024

2024 2023
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 1,207,175 1,043,635
Interest paid (406,355 ) (242,856 )
Tax paid (109,821 ) (241,339 )
Net cash from operating activities 690,999 559,440

Cash flows from investing activities
Purchase of tangible fixed assets (58,914 ) (168,666 )
Net cash from investing activities (58,914 ) (168,666 )

Cash flows from financing activities
Loan repayments in year (530,975 ) (599,761 )
Net cash from financing activities (530,975 ) (599,761 )

Increase/(decrease) in cash and cash equivalents 101,110 (208,987 )
Cash and cash equivalents at beginning of year 2 440,862 649,849

Cash and cash equivalents at end of year 2 541,972 440,862

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 JANUARY 2024

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS
2024 2023
£    £   
Profit before taxation 527,707 434,683
Depreciation charges 316,080 305,979
Reclassification of fixed asset 5,668 -
Finance costs 406,355 242,856
1,255,810 983,518
(Increase)/decrease in trade and other debtors (9,819 ) 5,355
(Decrease)/increase in trade and other creditors (38,816 ) 54,762
Cash generated from operations 1,207,175 1,043,635

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Statement of Cash Flows in respect of cash and cash equivalents are in respect of these Statement of Financial Position amounts:

Year ended 31 January 2024
31.1.24 1.2.23
£    £   
Cash and cash equivalents 541,972 440,862
Year ended 31 January 2023
31.1.23 1.2.22
£    £   
Cash and cash equivalents 440,862 649,849


3. ANALYSIS OF CHANGES IN NET DEBT

Other
non-cash
At 1.2.23 Cash flow changes At 31.1.24
£    £    £    £   
Net cash
Cash at bank
and in hand 440,862 101,110 541,972
440,862 101,110 541,972
Debt
Debts falling due
within 1 year (6,243,325 ) 5,642,025 - (601,300 )
Debts falling due
after 1 year - - (5,111,050 ) (5,111,050 )
(6,243,325 ) 5,642,025 (5,111,050 ) (5,712,350 )
Total (5,802,463 ) 5,743,135 (5,111,050 ) (5,170,378 )

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024

1. STATUTORY INFORMATION

United Health Group Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
In the application of the company's accounting policies, management is required to make judgements,
estimates and assumptions about the carrying value of assets and liabilities that are not readily apparent from
other sources. The estimates and underlying assumptions are based on historical experience and other factors
that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis and are covered within the accounting policies:

(i) The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are re-assessed annually. They are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of the assets. See note 8 for the carrying amount of the property plant and equipment, and accounting policy note for the usual economic lives of each class of assets.

(ii) The company makes an estimate of the recoverable value of trade and other debtors. When assessing impairment of trade and other debtors, management considers factors including the current credit rating of the debtor, ageing profile of debtors and historical experience. See note 9 for the net carrying amount of the debtors and associated impairment provision.

Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects.

Turnover
Turnover is measure at fair value of the consideration received or receivable and represents amounts receivable for services rendered in the provision of care.

Turnover is recognised in the period in which the services are provide and comprises residents fees and other ancillary services.

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Freehold property - 2% on cost
Furniture & fittings - 20% on cost and 15% on cost

No depreciation is charged on freehold property on the grounds of immateriality. Freehold property is subject to regular maintenance and repair such that in the opinion of the directors the residual value is not materially different from the value in the financial statements and has a long useful economic life. The directors consider the need for impairment at each period end.

Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

For the purpose of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, as estimate is made of the recoverable amount of the cash- generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that included the asset and generates cash inflows that largely independent of the cash inflows from other assets or group assets.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by class of business is given below:

2024 2023
£    £   
Rendering of services 5,382,120 4,814,462
5,382,120 4,814,462

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024

4. EMPLOYEES AND DIRECTORS
2024 2023
£    £   
Wages and salaries 2,726,195 2,488,728
Social security costs 179,519 169,198
Other pension costs 45,944 45,599
2,951,658 2,703,525

The average number of employees during the year was as follows:
2024 2023

Admin 3 3
Management 2 2
Nursing 7 7
Staff 155 148
Directors 2 2
169 162

2024 2023
£    £   
Directors' remuneration - -

5. OPERATING PROFIT

The operating profit is stated after charging:

2024 2023
£    £   
Apprenticeship levy 9,696 8,687
Depreciation - owned assets 316,080 305,979
Auditors' remuneration 10,185 9,795

6. INTEREST PAYABLE AND SIMILAR EXPENSES
2024 2023
£    £   
Bank loan interest 406,263 242,856
HMRC Interest 92 -
406,355 242,856

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024

7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2024 2023
£    £   
Current tax:
UK corporation tax 179,035 104,255
Adjustment re previous years 5,566 -
Total current tax 184,601 104,255

Deferred tax 873 29,529
Tax on profit 185,474 133,784

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2024 2023
£    £   
Profit before tax 527,707 434,683
Profit multiplied by the standard rate of corporation tax in the UK of 25% (2023 -
19%)

131,927

82,590

Effects of:
Expenses not deductible for tax purposes 331 9,613
Depreciation in excess of capital allowances 54,004 12,052
Adjustments to tax charge in respect of previous periods 5,566 -
Deferred tax 873 29,529
provision
Restatement of profits due to change in tax rates (7,227 ) -
Total tax charge 185,474 133,784

8. TANGIBLE FIXED ASSETS
Freehold Furniture
property & fittings Totals
£    £    £   
COST
At 1 February 2023 14,025,000 316,289 14,341,289
Additions - 58,914 58,914
Reclassification/transfer - (7,086 ) (7,086 )
At 31 January 2024 14,025,000 368,117 14,393,117
DEPRECIATION
At 1 February 2023 244,000 104,544 348,544
Charge for year 244,000 72,080 316,080
Reclassification/transfer - (1,417 ) (1,417 )
At 31 January 2024 488,000 175,207 663,207
NET BOOK VALUE
At 31 January 2024 13,537,000 192,910 13,729,910
At 31 January 2023 13,781,000 211,745 13,992,745

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024

8. TANGIBLE FIXED ASSETS - continued

Included in cost of land and buildings is freehold land of £ 1,825,000 (2023 - £ 1,825,000 ) which is not depreciated.

.

9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 222,418 198,314
Other debtors 599,089 612,327
VAT - 1,047
Deferred tax asset
Accelerated capital allowances 18,261 19,134
839,768 830,822

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts (see note 12) 601,300 6,243,325
Trade creditors 89,840 179,822
Taxation 179,035 104,255
Other taxes and social security 41,379 38,489
Other creditors 6,177,519 6,110,015
Accruals and deferred income 82,397 101,626
7,171,470 12,777,532

11. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans (see note 12) 5,111,050 -

12. LOANS

An analysis of the maturity of loans is given below:

2024 2023
£    £   
Amounts falling due within one year or on demand:
Bank loans 601,300 6,243,325

Amounts falling due between one and two years:
Bank loans - 1-2 years 601,300 -

Amounts falling due between two and five years:
Bank loans - 2-5 years 1,803,900 -

Amounts falling due in more than five years:

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024

12. LOANS - continued
2024 2023
£    £   
Amounts falling due in more than five years:
Repayable by instalments
Bank loans more than 5 years
by installments 2,705,850 -
2,705,850 -

13. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2024 2023
£    £   
Within one year 1,564 -
Between one and five years 4,007 -
5,571 -

14. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank loans 5,712,350 6,243,325

Charges are registered at Companies House to the company. There is a fixed charge to HSBC PLC for the freehold property known as the Valleys Care Home Scunthorpe, Bunkers Hill Care Home Lincoln, and a fixed and floating charge over all assets.

15. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
94,760 A Shares £0.00 5 474 474

16. RESERVES
Capital
Retained redemption
earnings reserve Totals
£    £    £   

At 1 February 2023 2,485,949 474 2,486,423
Profit for the year 342,233 342,233
At 31 January 2024 2,828,182 474 2,828,656

a) Capital redemption reserve

The capital redemption reserve represents the share capital repurchased by the company.

b) Retained earnings

The retained earnings account represents cumulative profits and losses net of dividends and other adjustments.

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024

17. PENSION COMMITMENTS

The company operates a defined contribution pension scheme. Contributions payable to the company pension scheme are charged to the income statement in the period they related. Pension contributions outstanding at the period end total £4,175 (2023: £3,471).

18. CONTINGENCIES

The company is a party to a composite cross guarantee given to the HSBC Bank Plc between Manor Homes (Yorkshire) Limited, United Health Group Limited, Barford Children's Services Limited, Creative Care & Therapy Limited, United Children's Services Limited, United Health Group 2 Limited, Manor Homes Property Company Limited and United Education Services Limited.

19. RELATED PARTY DISCLOSURES

Other related parties
2024 2023
£    £   
Amount due from related party 599,089 609,411
Amount due to related party 5,852,497 5,831,124

20. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is P J Pearson.

21. FUNDS HELD AS CUSTODIAN

The company holds fund on behalf of the residents of the homes and are only utilised at the instruction of the residents. The company does not hold any rights to these funds and they are held in separate bank and cash accounts. Therefore, these balances are not recognised in the financial statements.